These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21666488)

  • 1. Risk factors for developing multiple malignancies in patients with endometrial cancer.
    Uccella S; Cha SS; Melton LJ; Bergstralh EJ; Boardman LA; Keeney GL; Podratz KC; Ciancio FF; Mariani A
    Int J Gynecol Cancer; 2011 Jul; 21(5):896-901. PubMed ID: 21666488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma.
    Hemminki K; Aaltonen L; Li X
    Cancer; 2003 May; 97(10):2432-9. PubMed ID: 12733142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.
    Kok VC; Tsai HJ; Su CF; Lee CK
    Int J Gynecol Cancer; 2015 Jul; 25(6):968-76. PubMed ID: 25893280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
    Schoen RE; Weissfeld JL; Kuller LH
    Am J Gastroenterol; 1994 Jun; 89(6):835-42. PubMed ID: 8198091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
    Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
    Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family history and risk of endometrial cancer: a systematic review and meta-analysis.
    Win AK; Reece JC; Ryan S
    Obstet Gynecol; 2015 Jan; 125(1):89-98. PubMed ID: 25560109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.
    Ketabi Z; Gerdes AM; Mosgaard B; Ladelund S; Bernstein I
    Gynecol Oncol; 2014 Jun; 133(3):526-30. PubMed ID: 24631699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary cancer prevention during follow-up for endometrial cancer.
    Kwon JS; Elit L; Saskin R; Hodgson D; Grunfeld E
    Obstet Gynecol; 2009 Apr; 113(4):790-795. PubMed ID: 19305321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature.
    Dogan A; Schultheis B; Rezniczek GA; Hilal Z; Cetin C; Häusler G; Tempfer CB
    Anticancer Res; 2017 Mar; 37(3):969-978. PubMed ID: 28314254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study.
    AlHilli MM; Dowdy SC; Weaver AL; St Sauver JL; Keeney GL; Mariani A; Podratz KC; Bakkum-Gamez JN
    Gynecol Oncol; 2012 Apr; 125(1):109-13. PubMed ID: 22210467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological characteristics in hereditary nonpolyposis colorectal carcinoma-associated endometrial carcinoma].
    Wang YM; Zhu YB; Xue FX; Liu ZY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):286-9. PubMed ID: 18843971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonbreast second malignancies after treatment of primary breast cancer.
    Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gynecological malignancy risk in colorectal cancer survivors: A population-based cohort study.
    Chang WC; Muo CH; Liang JA; Sung FC; Kao CH
    Eur J Oncol Nurs; 2015 Oct; 19(5):473-8. PubMed ID: 25790918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand.
    Tangjitgamol S; Khunnarong J; Srijaipracharoen S
    J Gynecol Oncol; 2015 Oct; 26(4):293-302. PubMed ID: 26197770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Referral and ascertainment bias in patients with synchronous and metachronous endometrial malignancy.
    Mariani A; Cha SS; Bergstralh EJ; Boardman LA; Dowdy SC; Keeney GL; Podratz KC; Melton LJ
    Eur J Gynaecol Oncol; 2010; 31(1):5-9. PubMed ID: 20349773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
    J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma.
    Pan Z; Wang X; Zhang X; Chen X; Xie X
    J Obstet Gynaecol Res; 2011 Apr; 37(4):352-8. PubMed ID: 21314805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexisting ovarian malignancy in patients with clinical stage I endometrial carcinoma.
    Akbayır O; Kuru O; Goksedef P; Numanoglu C; Corbacıoglu A; Cetin A
    Arch Gynecol Obstet; 2012 Nov; 286(5):1241-5. PubMed ID: 22688443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.